【市場調査レポート】脊椎固定用生物製剤のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Spinal Fusion Biologics Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。脊椎固定用生物製剤のグローバル市場インサイト・予測（～2028年） / Global Spinal Fusion Biologics Market Insights, Forecast to 2028 / QY2207E10113資料のイメージです。

• レポートコード：QY2207E10113
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、114ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の脊椎固定用生物製剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に脊椎固定用生物製剤の世界市場のxxx％を占める「骨補填材」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の脊椎固定用生物製剤の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの脊椎固定用生物製剤市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの脊椎固定用生物製剤市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

脊椎固定用生物製剤のグローバル主要メーカーには、Medtronic、J &J (DePuy Synthes)、SeaSpine、Xtant Medical、Zimmer Biomet、Stryker、Straumann、Wright Medical Group、Hans Biomed、Arthrexなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

脊椎固定用生物製剤市場は、種類と用途によって区分されます。世界の脊椎固定用生物製剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
骨補填材、骨補填材代用材、多血小板血漿(PRP)、その他

【用途別セグメント】
病院、診療所、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 脊椎固定用生物製剤製品概要
- 種類別市場（骨補填材、骨補填材代用材、多血小板血漿(PRP)、その他）
- 用途別市場（病院、診療所、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の脊椎固定用生物製剤販売量予測2017-2028
- 世界の脊椎固定用生物製剤売上予測2017-2028
- 脊椎固定用生物製剤の地域別販売量
- 脊椎固定用生物製剤の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別脊椎固定用生物製剤販売量
- 主要メーカー別脊椎固定用生物製剤売上
- 主要メーカー別脊椎固定用生物製剤価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（骨補填材、骨補填材代用材、多血小板血漿(PRP)、その他）
- 脊椎固定用生物製剤の種類別販売量
- 脊椎固定用生物製剤の種類別売上
- 脊椎固定用生物製剤の種類別価格
・用途別市場規模（病院、診療所、その他）
- 脊椎固定用生物製剤の用途別販売量
- 脊椎固定用生物製剤の用途別売上
- 脊椎固定用生物製剤の用途別価格
・北米市場
- 北米の脊椎固定用生物製剤市場規模（種類別、用途別）
- 主要国別の脊椎固定用生物製剤市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの脊椎固定用生物製剤市場規模（種類別、用途別）
- 主要国別の脊椎固定用生物製剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の脊椎固定用生物製剤市場規模（種類別、用途別）
- 主要国別の脊椎固定用生物製剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の脊椎固定用生物製剤市場規模（種類別、用途別）
- 主要国別の脊椎固定用生物製剤市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの脊椎固定用生物製剤市場規模（種類別、用途別）
- 主要国別の脊椎固定用生物製剤市場規模（トルコ、サウジアラビア）
・企業情報
Medtronic、J &J (DePuy Synthes)、SeaSpine、Xtant Medical、Zimmer Biomet、Stryker、Straumann、Wright Medical Group、Hans Biomed、Arthrex
・産業チェーン及び販売チャネル分析
- 脊椎固定用生物製剤の産業チェーン分析
- 脊椎固定用生物製剤の原材料
- 脊椎固定用生物製剤の生産プロセス
- 脊椎固定用生物製剤の販売及びマーケティング
- 脊椎固定用生物製剤の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 脊椎固定用生物製剤の産業動向
- 脊椎固定用生物製剤のマーケットドライバー
- 脊椎固定用生物製剤の課題
- 脊椎固定用生物製剤の阻害要因
・主な調査結果

Spinal biologics are an important component of lumbar interbody spine fusion. Biologics are substances that work to alter the local environment by affecting cellular activity, growth, and differentiation through inherent properties of osteogenesis, osteoinduction, and osteoconduction.
Market Analysis and Insights: Global Spinal Fusion Biologics Market
Due to the COVID-19 pandemic, the global Spinal Fusion Biologics market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Bone Graft accounting for % of the Spinal Fusion Biologics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Spinal Fusion Biologics market size is valued at US$ million in 2021, while the US and Europe Spinal Fusion Biologics are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Spinal Fusion Biologics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Spinal Fusion Biologics include Medtronic, J &J (DePuy Synthes), SeaSpine, Xtant Medical, Zimmer Biomet, Stryker, Straumann, Wright Medical Group and Hans Biomed and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Spinal Fusion Biologics Scope and Segment
Spinal Fusion Biologics market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Spinal Fusion Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
Other
Segment by Application
Hospital
Clinic
Other
By Company
Medtronic
J &J (DePuy Synthes)
SeaSpine
Xtant Medical
Zimmer Biomet
Stryker
Straumann
Wright Medical Group
Hans Biomed
Arthrex
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Spinal Fusion Biologics Product Introduction
1.2 Market by Type
1.2.1 Global Spinal Fusion Biologics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Bone Graft
1.2.3 Bone Graft Substitute
1.2.4 Platelet Rich Plasma (PRP)
1.2.5 Other
1.3 Market by Application
1.3.1 Global Spinal Fusion Biologics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Spinal Fusion Biologics Sales Estimates and Forecasts 2017-2028
2.2 Global Spinal Fusion Biologics Revenue Estimates and Forecasts 2017-2028
2.3 Global Spinal Fusion Biologics Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Spinal Fusion Biologics Sales by Region
2.4.1 Global Spinal Fusion Biologics Sales by Region (2017-2022)
2.4.2 Global Sales Spinal Fusion Biologics by Region (2023-2028)
2.5 Global Spinal Fusion Biologics Revenue by Region
2.5.1 Global Spinal Fusion Biologics Revenue by Region (2017-2022)
2.5.2 Global Spinal Fusion Biologics Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Spinal Fusion Biologics Sales by Manufacturers
3.1.1 Global Top Spinal Fusion Biologics Manufacturers by Sales (2017-2022)
3.1.2 Global Spinal Fusion Biologics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Spinal Fusion Biologics in 2021
3.2 Global Spinal Fusion Biologics Revenue by Manufacturers
3.2.1 Global Spinal Fusion Biologics Revenue by Manufacturers (2017-2022)
3.2.2 Global Spinal Fusion Biologics Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Spinal Fusion Biologics Revenue in 2021
3.3 Global Spinal Fusion Biologics Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Spinal Fusion Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Spinal Fusion Biologics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Spinal Fusion Biologics Sales by Type
4.1.1 Global Spinal Fusion Biologics Historical Sales by Type (2017-2022)
4.1.2 Global Spinal Fusion Biologics Forecasted Sales by Type (2023-2028)
4.1.3 Global Spinal Fusion Biologics Sales Market Share by Type (2017-2028)
4.2 Global Spinal Fusion Biologics Revenue by Type
4.2.1 Global Spinal Fusion Biologics Historical Revenue by Type (2017-2022)
4.2.2 Global Spinal Fusion Biologics Forecasted Revenue by Type (2023-2028)
4.2.3 Global Spinal Fusion Biologics Revenue Market Share by Type (2017-2028)
4.3 Global Spinal Fusion Biologics Price by Type
4.3.1 Global Spinal Fusion Biologics Price by Type (2017-2022)
4.3.2 Global Spinal Fusion Biologics Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Spinal Fusion Biologics Sales by Application
5.1.1 Global Spinal Fusion Biologics Historical Sales by Application (2017-2022)
5.1.2 Global Spinal Fusion Biologics Forecasted Sales by Application (2023-2028)
5.1.3 Global Spinal Fusion Biologics Sales Market Share by Application (2017-2028)
5.2 Global Spinal Fusion Biologics Revenue by Application
5.2.1 Global Spinal Fusion Biologics Historical Revenue by Application (2017-2022)
5.2.2 Global Spinal Fusion Biologics Forecasted Revenue by Application (2023-2028)
5.2.3 Global Spinal Fusion Biologics Revenue Market Share by Application (2017-2028)
5.3 Global Spinal Fusion Biologics Price by Application
5.3.1 Global Spinal Fusion Biologics Price by Application (2017-2022)
5.3.2 Global Spinal Fusion Biologics Price Forecast by Application (2023-2028)
6 North America
6.1 North America Spinal Fusion Biologics Market Size by Type
6.1.1 North America Spinal Fusion Biologics Sales by Type (2017-2028)
6.1.2 North America Spinal Fusion Biologics Revenue by Type (2017-2028)
6.2 North America Spinal Fusion Biologics Market Size by Application
6.2.1 North America Spinal Fusion Biologics Sales by Application (2017-2028)
6.2.2 North America Spinal Fusion Biologics Revenue by Application (2017-2028)
6.3 North America Spinal Fusion Biologics Market Size by Country
6.3.1 North America Spinal Fusion Biologics Sales by Country (2017-2028)
6.3.2 North America Spinal Fusion Biologics Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Spinal Fusion Biologics Market Size by Type
7.1.1 Europe Spinal Fusion Biologics Sales by Type (2017-2028)
7.1.2 Europe Spinal Fusion Biologics Revenue by Type (2017-2028)
7.2 Europe Spinal Fusion Biologics Market Size by Application
7.2.1 Europe Spinal Fusion Biologics Sales by Application (2017-2028)
7.2.2 Europe Spinal Fusion Biologics Revenue by Application (2017-2028)
7.3 Europe Spinal Fusion Biologics Market Size by Country
7.3.1 Europe Spinal Fusion Biologics Sales by Country (2017-2028)
7.3.2 Europe Spinal Fusion Biologics Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Spinal Fusion Biologics Market Size by Type
8.1.1 Asia Pacific Spinal Fusion Biologics Sales by Type (2017-2028)
8.1.2 Asia Pacific Spinal Fusion Biologics Revenue by Type (2017-2028)
8.2 Asia Pacific Spinal Fusion Biologics Market Size by Application
8.2.1 Asia Pacific Spinal Fusion Biologics Sales by Application (2017-2028)
8.2.2 Asia Pacific Spinal Fusion Biologics Revenue by Application (2017-2028)
8.3 Asia Pacific Spinal Fusion Biologics Market Size by Region
8.3.1 Asia Pacific Spinal Fusion Biologics Sales by Region (2017-2028)
8.3.2 Asia Pacific Spinal Fusion Biologics Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Spinal Fusion Biologics Market Size by Type
9.1.1 Latin America Spinal Fusion Biologics Sales by Type (2017-2028)
9.1.2 Latin America Spinal Fusion Biologics Revenue by Type (2017-2028)
9.2 Latin America Spinal Fusion Biologics Market Size by Application
9.2.1 Latin America Spinal Fusion Biologics Sales by Application (2017-2028)
9.2.2 Latin America Spinal Fusion Biologics Revenue by Application (2017-2028)
9.3 Latin America Spinal Fusion Biologics Market Size by Country
9.3.1 Latin America Spinal Fusion Biologics Sales by Country (2017-2028)
9.3.2 Latin America Spinal Fusion Biologics Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Spinal Fusion Biologics Market Size by Type
10.1.1 Middle East and Africa Spinal Fusion Biologics Sales by Type (2017-2028)
10.1.2 Middle East and Africa Spinal Fusion Biologics Revenue by Type (2017-2028)
10.2 Middle East and Africa Spinal Fusion Biologics Market Size by Application
10.2.1 Middle East and Africa Spinal Fusion Biologics Sales by Application (2017-2028)
10.2.2 Middle East and Africa Spinal Fusion Biologics Revenue by Application (2017-2028)
10.3 Middle East and Africa Spinal Fusion Biologics Market Size by Country
10.3.1 Middle East and Africa Spinal Fusion Biologics Sales by Country (2017-2028)
10.3.2 Middle East and Africa Spinal Fusion Biologics Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Overview
11.1.3 Medtronic Spinal Fusion Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Medtronic Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medtronic Recent Developments
11.2 J &J (DePuy Synthes)
11.2.1 J &J (DePuy Synthes) Corporation Information
11.2.2 J &J (DePuy Synthes) Overview
11.2.3 J &J (DePuy Synthes) Spinal Fusion Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 J &J (DePuy Synthes) Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 J &J (DePuy Synthes) Recent Developments
11.3 SeaSpine
11.3.1 SeaSpine Corporation Information
11.3.2 SeaSpine Overview
11.3.3 SeaSpine Spinal Fusion Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 SeaSpine Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 SeaSpine Recent Developments
11.4 Xtant Medical
11.4.1 Xtant Medical Corporation Information
11.4.2 Xtant Medical Overview
11.4.3 Xtant Medical Spinal Fusion Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Xtant Medical Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Xtant Medical Recent Developments
11.5 Zimmer Biomet
11.5.1 Zimmer Biomet Corporation Information
11.5.2 Zimmer Biomet Overview
11.5.3 Zimmer Biomet Spinal Fusion Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Zimmer Biomet Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Zimmer Biomet Recent Developments
11.6 Stryker
11.6.1 Stryker Corporation Information
11.6.2 Stryker Overview
11.6.3 Stryker Spinal Fusion Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Stryker Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Stryker Recent Developments
11.7 Straumann
11.7.1 Straumann Corporation Information
11.7.2 Straumann Overview
11.7.3 Straumann Spinal Fusion Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Straumann Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Straumann Recent Developments
11.8 Wright Medical Group
11.8.1 Wright Medical Group Corporation Information
11.8.2 Wright Medical Group Overview
11.8.3 Wright Medical Group Spinal Fusion Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Wright Medical Group Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Wright Medical Group Recent Developments
11.9 Hans Biomed
11.9.1 Hans Biomed Corporation Information
11.9.2 Hans Biomed Overview
11.9.3 Hans Biomed Spinal Fusion Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Hans Biomed Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hans Biomed Recent Developments
11.10 Arthrex
11.10.1 Arthrex Corporation Information
11.10.2 Arthrex Overview
11.10.3 Arthrex Spinal Fusion Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Arthrex Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Arthrex Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Spinal Fusion Biologics Industry Chain Analysis
12.2 Spinal Fusion Biologics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Spinal Fusion Biologics Production Mode & Process
12.4 Spinal Fusion Biologics Sales and Marketing
12.4.1 Spinal Fusion Biologics Sales Channels
12.4.2 Spinal Fusion Biologics Distributors
12.5 Spinal Fusion Biologics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Spinal Fusion Biologics Industry Trends
13.2 Spinal Fusion Biologics Market Drivers
13.3 Spinal Fusion Biologics Market Challenges
13.4 Spinal Fusion Biologics Market Restraints
14 Key Findings in The Global Spinal Fusion Biologics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Spinal Fusion Biologics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Bone Graft
Table 3. Major Manufacturers of Bone Graft Substitute
Table 4. Major Manufacturers of Platelet Rich Plasma (PRP)
Table 5. Major Manufacturers of Other
Table 6. Global Spinal Fusion Biologics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Spinal Fusion Biologics Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Spinal Fusion Biologics Sales by Region (2017-2022) & (Units)
Table 9. Global Spinal Fusion Biologics Sales Market Share by Region (2017-2022)
Table 10. Global Spinal Fusion Biologics Sales by Region (2023-2028) & (Units)
Table 11. Global Spinal Fusion Biologics Sales Market Share by Region (2023-2028)
Table 12. Global Spinal Fusion Biologics Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Spinal Fusion Biologics Revenue Market Share by Region (2017-2022)
Table 14. Global Spinal Fusion Biologics Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Spinal Fusion Biologics Revenue Market Share by Region (2023-2028)
Table 16. Global Spinal Fusion Biologics Sales by Manufacturers (2017-2022) & (Units)
Table 17. Global Spinal Fusion Biologics Sales Share by Manufacturers (2017-2022)
Table 18. Global Spinal Fusion Biologics Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Spinal Fusion Biologics Revenue Share by Manufacturers (2017-2022)
Table 20. Spinal Fusion Biologics Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Spinal Fusion Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Spinal Fusion Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Fusion Biologics as of 2021)
Table 23. Spinal Fusion Biologics Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Spinal Fusion Biologics Product Offered
Table 25. Date of Manufacturers Enter into Spinal Fusion Biologics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Spinal Fusion Biologics Sales by Type (2017-2022) & (Units)
Table 28. Global Spinal Fusion Biologics Sales by Type (2023-2028) & (Units)
Table 29. Global Spinal Fusion Biologics Sales Share by Type (2017-2022)
Table 30. Global Spinal Fusion Biologics Sales Share by Type (2023-2028)
Table 31. Global Spinal Fusion Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Spinal Fusion Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Spinal Fusion Biologics Revenue Share by Type (2017-2022)
Table 34. Global Spinal Fusion Biologics Revenue Share by Type (2023-2028)
Table 35. Spinal Fusion Biologics Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Spinal Fusion Biologics Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Spinal Fusion Biologics Sales by Application (2017-2022) & (Units)
Table 38. Global Spinal Fusion Biologics Sales by Application (2023-2028) & (Units)
Table 39. Global Spinal Fusion Biologics Sales Share by Application (2017-2022)
Table 40. Global Spinal Fusion Biologics Sales Share by Application (2023-2028)
Table 41. Global Spinal Fusion Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Spinal Fusion Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Spinal Fusion Biologics Revenue Share by Application (2017-2022)
Table 44. Global Spinal Fusion Biologics Revenue Share by Application (2023-2028)
Table 45. Spinal Fusion Biologics Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Spinal Fusion Biologics Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Spinal Fusion Biologics Sales by Type (2017-2022) & (Units)
Table 48. North America Spinal Fusion Biologics Sales by Type (2023-2028) & (Units)
Table 49. North America Spinal Fusion Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Spinal Fusion Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Spinal Fusion Biologics Sales by Application (2017-2022) & (Units)
Table 52. North America Spinal Fusion Biologics Sales by Application (2023-2028) & (Units)
Table 53. North America Spinal Fusion Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Spinal Fusion Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Spinal Fusion Biologics Sales by Country (2017-2022) & (Units)
Table 56. North America Spinal Fusion Biologics Sales by Country (2023-2028) & (Units)
Table 57. North America Spinal Fusion Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Spinal Fusion Biologics Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Spinal Fusion Biologics Sales by Type (2017-2022) & (Units)
Table 60. Europe Spinal Fusion Biologics Sales by Type (2023-2028) & (Units)
Table 61. Europe Spinal Fusion Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Spinal Fusion Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Spinal Fusion Biologics Sales by Application (2017-2022) & (Units)
Table 64. Europe Spinal Fusion Biologics Sales by Application (2023-2028) & (Units)
Table 65. Europe Spinal Fusion Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Spinal Fusion Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Spinal Fusion Biologics Sales by Country (2017-2022) & (Units)
Table 68. Europe Spinal Fusion Biologics Sales by Country (2023-2028) & (Units)
Table 69. Europe Spinal Fusion Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Spinal Fusion Biologics Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Spinal Fusion Biologics Sales by Type (2017-2022) & (Units)
Table 72. Asia Pacific Spinal Fusion Biologics Sales by Type (2023-2028) & (Units)
Table 73. Asia Pacific Spinal Fusion Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Spinal Fusion Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Spinal Fusion Biologics Sales by Application (2017-2022) & (Units)
Table 76. Asia Pacific Spinal Fusion Biologics Sales by Application (2023-2028) & (Units)
Table 77. Asia Pacific Spinal Fusion Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Spinal Fusion Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Spinal Fusion Biologics Sales by Region (2017-2022) & (Units)
Table 80. Asia Pacific Spinal Fusion Biologics Sales by Region (2023-2028) & (Units)
Table 81. Asia Pacific Spinal Fusion Biologics Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Spinal Fusion Biologics Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Spinal Fusion Biologics Sales by Type (2017-2022) & (Units)
Table 84. Latin America Spinal Fusion Biologics Sales by Type (2023-2028) & (Units)
Table 85. Latin America Spinal Fusion Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Spinal Fusion Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Spinal Fusion Biologics Sales by Application (2017-2022) & (Units)
Table 88. Latin America Spinal Fusion Biologics Sales by Application (2023-2028) & (Units)
Table 89. Latin America Spinal Fusion Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Spinal Fusion Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Spinal Fusion Biologics Sales by Country (2017-2022) & (Units)
Table 92. Latin America Spinal Fusion Biologics Sales by Country (2023-2028) & (Units)
Table 93. Latin America Spinal Fusion Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Spinal Fusion Biologics Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Spinal Fusion Biologics Sales by Type (2017-2022) & (Units)
Table 96. Middle East and Africa Spinal Fusion Biologics Sales by Type (2023-2028) & (Units)
Table 97. Middle East and Africa Spinal Fusion Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Spinal Fusion Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Spinal Fusion Biologics Sales by Application (2017-2022) & (Units)
Table 100. Middle East and Africa Spinal Fusion Biologics Sales by Application (2023-2028) & (Units)
Table 101. Middle East and Africa Spinal Fusion Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Spinal Fusion Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Spinal Fusion Biologics Sales by Country (2017-2022) & (Units)
Table 104. Middle East and Africa Spinal Fusion Biologics Sales by Country (2023-2028) & (Units)
Table 105. Middle East and Africa Spinal Fusion Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Spinal Fusion Biologics Revenue by Country (2023-2028) & (US$ Million)
Table 107. Medtronic Corporation Information
Table 108. Medtronic Description and Major Businesses
Table 109. Medtronic Spinal Fusion Biologics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Medtronic Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Medtronic Recent Developments
Table 112. J &J (DePuy Synthes) Corporation Information
Table 113. J &J (DePuy Synthes) Description and Major Businesses
Table 114. J &J (DePuy Synthes) Spinal Fusion Biologics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. J &J (DePuy Synthes) Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. J &J (DePuy Synthes) Recent Developments
Table 117. SeaSpine Corporation Information
Table 118. SeaSpine Description and Major Businesses
Table 119. SeaSpine Spinal Fusion Biologics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. SeaSpine Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. SeaSpine Recent Developments
Table 122. Xtant Medical Corporation Information
Table 123. Xtant Medical Description and Major Businesses
Table 124. Xtant Medical Spinal Fusion Biologics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Xtant Medical Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Xtant Medical Recent Developments
Table 127. Zimmer Biomet Corporation Information
Table 128. Zimmer Biomet Description and Major Businesses
Table 129. Zimmer Biomet Spinal Fusion Biologics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Zimmer Biomet Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Zimmer Biomet Recent Developments
Table 132. Stryker Corporation Information
Table 133. Stryker Description and Major Businesses
Table 134. Stryker Spinal Fusion Biologics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Stryker Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Stryker Recent Developments
Table 137. Straumann Corporation Information
Table 138. Straumann Description and Major Businesses
Table 139. Straumann Spinal Fusion Biologics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Straumann Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Straumann Recent Developments
Table 142. Wright Medical Group Corporation Information
Table 143. Wright Medical Group Description and Major Businesses
Table 144. Wright Medical Group Spinal Fusion Biologics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Wright Medical Group Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Wright Medical Group Recent Developments
Table 147. Hans Biomed Corporation Information
Table 148. Hans Biomed Description and Major Businesses
Table 149. Hans Biomed Spinal Fusion Biologics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Hans Biomed Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Hans Biomed Recent Developments
Table 152. Arthrex Corporation Information
Table 153. Arthrex Description and Major Businesses
Table 154. Arthrex Spinal Fusion Biologics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Arthrex Spinal Fusion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Arthrex Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Spinal Fusion Biologics Distributors List
Table 160. Spinal Fusion Biologics Customers List
Table 161. Spinal Fusion Biologics Market Trends
Table 162. Spinal Fusion Biologics Market Drivers
Table 163. Spinal Fusion Biologics Market Challenges
Table 164. Spinal Fusion Biologics Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Spinal Fusion Biologics Product Picture
Figure 3. Global Spinal Fusion Biologics Market Share by Type in 2021 & 2028
Figure 3. Bone Graft Product Picture
Figure 4. Bone Graft Substitute Product Picture
Figure 5. Platelet Rich Plasma (PRP) Product Picture
Figure 6. Other Product Picture
Figure 7. Global Spinal Fusion Biologics Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Spinal Fusion Biologics Report Years Considered
Figure 12. Global Spinal Fusion Biologics Sales 2017-2028 (Units)
Figure 13. Global Spinal Fusion Biologics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Spinal Fusion Biologics Revenue 2017-2028 (US$ Million)
Figure 15. Global Spinal Fusion Biologics Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Spinal Fusion Biologics Sales Market Share by Region (2017-2022)
Figure 17. Global Spinal Fusion Biologics Sales Market Share by Region (2023-2028)
Figure 18. North America Spinal Fusion Biologics Sales YoY (2017-2028) & (Units)
Figure 19. North America Spinal Fusion Biologics Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Spinal Fusion Biologics Sales YoY (2017-2028) & (Units)
Figure 21. Europe Spinal Fusion Biologics Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Spinal Fusion Biologics Sales YoY (2017-2028) & (Units)
Figure 23. Asia-Pacific Spinal Fusion Biologics Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Spinal Fusion Biologics Sales YoY (2017-2028) & (Units)
Figure 25. Latin America Spinal Fusion Biologics Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Spinal Fusion Biologics Sales YoY (2017-2028) & (Units)
Figure 27. Middle East & Africa Spinal Fusion Biologics Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Spinal Fusion Biologics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Spinal Fusion Biologics in the World: Market Share by Spinal Fusion Biologics Revenue in 2021
Figure 30. Global Spinal Fusion Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Spinal Fusion Biologics Sales Market Share by Type (2017-2028)
Figure 32. Global Spinal Fusion Biologics Revenue Market Share by Type (2017-2028)
Figure 33. Global Spinal Fusion Biologics Sales Market Share by Application (2017-2028)
Figure 34. Global Spinal Fusion Biologics Revenue Market Share by Application (2017-2028)
Figure 35. North America Spinal Fusion Biologics Sales Market Share by Type (2017-2028)
Figure 36. North America Spinal Fusion Biologics Revenue Market Share by Type (2017-2028)
Figure 37. North America Spinal Fusion Biologics Sales Market Share by Application (2017-2028)
Figure 38. North America Spinal Fusion Biologics Revenue Market Share by Application (2017-2028)
Figure 39. North America Spinal Fusion Biologics Sales Share by Country (2017-2028)
Figure 40. North America Spinal Fusion Biologics Revenue Share by Country (2017-2028)
Figure 41. United States Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Spinal Fusion Biologics Sales Market Share by Type (2017-2028)
Figure 44. Europe Spinal Fusion Biologics Revenue Market Share by Type (2017-2028)
Figure 45. Europe Spinal Fusion Biologics Sales Market Share by Application (2017-2028)
Figure 46. Europe Spinal Fusion Biologics Revenue Market Share by Application (2017-2028)
Figure 47. Europe Spinal Fusion Biologics Sales Share by Country (2017-2028)
Figure 48. Europe Spinal Fusion Biologics Revenue Share by Country (2017-2028)
Figure 49. Germany Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 50. France Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Spinal Fusion Biologics Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Spinal Fusion Biologics Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Spinal Fusion Biologics Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Spinal Fusion Biologics Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Spinal Fusion Biologics Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Spinal Fusion Biologics Revenue Share by Region (2017-2028)
Figure 60. China Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 63. India Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Spinal Fusion Biologics Sales Market Share by Type (2017-2028)
Figure 70. Latin America Spinal Fusion Biologics Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Spinal Fusion Biologics Sales Market Share by Application (2017-2028)
Figure 72. Latin America Spinal Fusion Biologics Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Spinal Fusion Biologics Sales Share by Country (2017-2028)
Figure 74. Latin America Spinal Fusion Biologics Revenue Share by Country (2017-2028)
Figure 75. Mexico Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Spinal Fusion Biologics Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Spinal Fusion Biologics Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Spinal Fusion Biologics Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Spinal Fusion Biologics Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Spinal Fusion Biologics Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Spinal Fusion Biologics Revenue Share by Country (2017-2028)
Figure 84. Turkey Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Spinal Fusion Biologics Revenue (2017-2028) & (US$ Million)
Figure 87. Spinal Fusion Biologics Value Chain
Figure 88. Spinal Fusion Biologics Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

以下、関連資料のご紹介

転移性脊椎腫瘍手術のグローバル市場インサイト・予測（～2028年）

Global Metastases Spinal Tumor Surgery Market Insights, Forecast to 2028
QY2207E09251 2022年7月 111Pages
新型コロナウイルス感染症のパンデミックにより、世界の転移性脊椎腫瘍手術の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に転移性脊椎腫瘍手術...

脊髄液マノメーターのグローバル市場インサイト・予測（～2028年）

Global Spinal Fluid Manometer Market Insights, Forecast to 2028
QY2207E10112 2022年7月 96Pages
新型コロナウイルス感染症のパンデミックにより、世界の脊髄液マノメーターの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に脊髄液マノメーター...

椎体間脊椎インプラントのグローバル市場インサイト・予測（～2028年）

Global Interbody Spinal Implants Market Insights, Forecast to 2028
QY2207E09607 2022年7月 127Pages
新型コロナウイルス感染症のパンデミックにより、世界の椎体間脊椎インプラントの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に椎体間脊椎イン...

世界の脊髄刺激（SCS）システム市場予測（～2028年）：従来型、無線周波数、その他

Global Spinal Cord Stimulation (SCS) Systems Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E8407 2022年5月 94Pages
脊髄刺激（SCS）システム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供...

世界の脊椎減圧装置市場予測（～2028年）：電気調整、手動調整

Global Spinal Decompression Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E8409 2022年5月 108Pages
脊椎減圧装置市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。

転移性脊椎腫瘍手術のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Metastases Spinal Tumor Surgery Market The global Metastases Spinal Tumor Surgery market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Minima…
脊髄液マノメーターのグローバル市場インサイト・予測（～2028年） The Spinal Manometer is designed to check out the pressure of the cerebrospinal fluid by using a needle, which is inserted into the spine. Market Analysis and Insights: Global Spinal Fluid Manometer Market Due to the COVID-19 pandemic, the global Spinal Fluid Manometer market size is estimated to be…
世界の骨・筋骨格移植片市場予測（～2028年）：皮質細胞移植片、巨大構造移植片、骨誘導性移植片 The Bone and Musculoskeletal Allografts market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
世界の脊髄刺激（SCS）システム市場予測（～2028年）：従来型、無線周波数、その他 The Spinal Cord Stimulation (SCS) Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
椎体間脊椎インプラントのグローバル市場インサイト・予測（～2028年） Interbody spine implant is a prosthesis used in spinal fusion surgery to maintain the height of intervertebral foramen and reduce pressure. They are cylindrical or square devices, usually with threads. Market Analysis and Insights: Global Interbody Spinal Implants Market Due to the COVID-19 pandemic…